PATH Intl.

PATH is a premier global health non-profit organization that operates as a product development partnership (PDP), accelerating the development and deployment of high-impact health solutions for low-resource settings. The organization works across the entire product lifecycle, from laboratory research and clinical trials to regulatory approval and large-scale introduction. PATH's extensive portfolio includes landmark achievements such as the development of the MenAfriVac vaccine for meningitis A and the RTS,S malaria vaccine in collaboration with GSK. By bridging the gap between scientific innovation and global health equity, PATH collaborates with pharmaceutical companies, governments, and international agencies to tackle infectious diseases and improve health outcomes worldwide.